Mraz, Amerine & Associates »

Blueprint Medicines shares owned by Mraz, Amerine & Associates

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Mraz, Amerine & Associates from 13F filings

Historical chart of Mraz, Amerine & Associates investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by Mraz, Amerine & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by Mraz, Amerine & Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $582k 6.3k 92.24
2023-09-30 $317k 6.3k 50.22
2023-06-30 $415k 6.6k 63.20
2023-03-31 $296k 6.6k 44.99

More positions owned by Mraz, Amerine & Associates

Berkshire Hathaway Inc Del Cl B New (BRK.B)
White Mountains Insurance Gp (WTM)
W.R. Berkley Corporation (WRB)
Enstar Group SHS (ESGR)
Fairfax Finl Hldgs Ltd Sub Vtg Stock (FRFHF)
Markel Corporation (MKL)
Jefferies Finl Group (JEF)
Loews Corporation (L)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Microsoft Corporation (MSFT)
Credit Acceptance (CACC)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
U Haul Holding Company Com Ser N (UHAL.B)
Canadian Natural Resources (CNQ)
Brookfield Corp Cl A Ltd Vt Sh (BN)

View all positions for Mraz, Amerine & Associates

Top funds holding Blueprint Medicines

Vanguard Group
T. Rowe Price Associates
Wellington Management Company
William Blair Investment Management
Jpmorgan Chase & Co
Lord, Abbett & Co
Alliancebernstein
Brown Advisory Holdings Incorporated
Avidity Partners Management
Norges Bank Investment Management
Goldman Sachs Group
Charles Schwab Investment Management
Emerald Advisers
Point72 Asset Management
Bank of America Corporation

View all funds holding Blueprint Medicines